2022 Q3 Form 10-Q Financial Statement

#000143774922020389 Filed on August 12, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $3.087M $3.196M $2.422M
YoY Change 52.75% 31.31% 24.85%
% of Gross Profit
Research & Development $5.965M $4.204M $4.620M
YoY Change 45.67% 38.33% 12.55%
% of Gross Profit
Depreciation & Amortization $32.00K $34.00K $32.00K
YoY Change -21.95% -22.73% -27.27%
% of Gross Profit
Operating Expenses $9.084M $7.434M $7.074M
YoY Change 47.54% 34.75% 16.2%
Operating Profit -$9.084M -$7.434M -$7.074M
YoY Change 47.54% 34.75% 16.2%
Interest Expense $454.0K $642.0K $202.0K
YoY Change -74.28% -49.25% -87.61%
% of Operating Profit
Other Income/Expense, Net $19.00K $15.00K $5.000K
YoY Change 46.15% 87.5% -44.44%
Pretax Income -$8.611M -$6.777M -$6.867M
YoY Change 96.64% 59.68% 54.31%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$8.611M -$6.777M -$6.867M
YoY Change 96.64% 59.68% 54.49%
Net Earnings / Revenue
Basic Earnings Per Share -$0.30 -$0.24 -$0.24
Diluted Earnings Per Share -$300.8K -$237.1K -$240.3K
COMMON SHARES
Basic Shares Outstanding 28.61M 28.58M 28.58M
Diluted Shares Outstanding

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $50.39M $58.00M $66.10M
YoY Change -32.97% -27.05% -23.39%
Cash & Equivalents $50.40M $58.00M $66.10M
Short-Term Investments
Other Short-Term Assets $1.751M $2.171M $805.0K
YoY Change -7.45% -6.82% -53.47%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $53.49M $61.32M $67.26M
YoY Change -30.59% -25.07% -23.58%
LONG-TERM ASSETS
Property, Plant & Equipment $306.0K $339.0K $312.0K
YoY Change -13.31% -14.18% -28.77%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $11.88M $11.93M $11.54M
YoY Change 2.12% 2.01% -1.9%
TOTAL ASSETS
Total Short-Term Assets $53.49M $61.32M $67.26M
Total Long-Term Assets $11.88M $11.93M $11.54M
Total Assets $65.37M $73.26M $78.80M
YoY Change -26.3% -21.68% -21.03%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.568M $3.184M $2.224M
YoY Change 156.69% 111.56% 15.35%
Accrued Expenses $2.794M $2.675M $2.610M
YoY Change 23.3% 44.99% -1.51%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $6.362M $5.859M $4.834M
YoY Change 74.02% 74.9% 5.59%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $593.0K $1.037M $1.302M
YoY Change -84.34% -81.09% -80.54%
Total Long-Term Liabilities $593.0K $1.037M $1.302M
YoY Change -84.34% -81.09% -80.54%
TOTAL LIABILITIES
Total Short-Term Liabilities $6.362M $5.859M $4.834M
Total Long-Term Liabilities $593.0K $1.037M $1.302M
Total Liabilities $6.955M $6.896M $6.136M
YoY Change -6.56% -21.94% -45.54%
SHAREHOLDERS EQUITY
Retained Earnings -$95.10M -$86.50M -$79.70M
YoY Change 35.86% 31.86% 29.8%
Common Stock $153.5M $152.8M $152.3M
YoY Change 1.5% 1.68% 1.65%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $58.42M $66.36M $72.67M
YoY Change
Total Liabilities & Shareholders Equity $65.37M $73.26M $78.80M
YoY Change -26.3% -21.68% -21.03%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1
OPERATING ACTIVITIES
Net Income -$8.611M -$6.777M -$6.867M
YoY Change 96.64% 59.68% 54.49%
Depreciation, Depletion And Amortization $32.00K $34.00K $32.00K
YoY Change -21.95% -22.73% -27.27%
Cash From Operating Activities -$7.577M -$8.001M -$4.800M
YoY Change 76.7% 17.92% 33.33%
INVESTING ACTIVITIES
Capital Expenditures $0.00 -$61.00K $6.000K
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00 -$61.00K -$6.000K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change -100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -11.00K -12.00K $0.00
YoY Change -54.17% 500.0% -100.0%
NET CHANGE
Cash From Operating Activities -7.577M -8.001M -$4.800M
Cash From Investing Activities 0.000 -61.00K -$6.000K
Cash From Financing Activities -11.00K -12.00K $0.00
Net Change In Cash -7.588M -8.074M -$4.799M
YoY Change 75.97% 18.96% -106.75%
FREE CASH FLOW
Cash From Operating Activities -$7.577M -$8.001M -$4.800M
Capital Expenditures $0.00 -$61.00K $6.000K
Free Cash Flow -$7.577M -$7.940M -$4.806M
YoY Change 76.7% 17.02% 33.5%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2022Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
28606706
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
28606706
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
28578338
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
28578338
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
6159000 usd
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
403000 usd
CY2022Q2 mbrx Number Of Core Drug Technologies
NumberOfCoreDrugTechnologies
3 pure
CY2022Q2 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
48000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0 pure
CY2021Q2 us-gaap Sublease Income
SubleaseIncome
10000 usd
us-gaap Sublease Income
SubleaseIncome
21000 usd
CY2021Q2 mbrx License Agreements Expense
LicenseAgreementsExpense
56000 usd
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-37758
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
47-4671997
dei Entity Address Address Line1
EntityAddressAddressLine1
5300 Memorial Drive, Suite 950
dei Entity Address City Or Town
EntityAddressCityOrTown
Houston
dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
77007
dei City Area Code
CityAreaCode
713
dei Local Phone Number
LocalPhoneNumber
300-5160
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
dei Trading Symbol
TradingSymbol
MBRX
dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
28606706
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
57999000 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
70903000 usd
CY2022Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3323000 usd
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1594000 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
61322000 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
72497000 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
339000 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
338000 usd
CY2022Q2 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
11148000 usd
CY2021Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
11148000 usd
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
446000 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
107000 usd
CY2022Q2 us-gaap Assets
Assets
73255000 usd
CY2021Q4 us-gaap Assets
Assets
84090000 usd
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
3184000 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1364000 usd
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2675000 usd
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2258000 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
5859000 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3622000 usd
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
388000 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
63000 usd
CY2022Q2 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
649000 usd
CY2021Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
1412000 usd
CY2022Q2 us-gaap Liabilities
Liabilities
6896000 usd
CY2021Q4 us-gaap Liabilities
Liabilities
5097000 usd
CY2022Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
29000 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
29000 usd
CY2022Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
152762000 usd
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
151733000 usd
CY2022Q2 us-gaap Aoci Before Tax Attributable To Parent
AociBeforeTaxAttributableToParent
22000 usd
CY2021Q4 us-gaap Aoci Before Tax Attributable To Parent
AociBeforeTaxAttributableToParent
41000 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-86454000 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-72810000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
66359000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
78993000 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
73255000 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
84090000 usd
CY2022Q2 us-gaap Revenues
Revenues
0 usd
CY2021Q2 us-gaap Revenues
Revenues
0 usd
us-gaap Revenues
Revenues
0 usd
us-gaap Revenues
Revenues
0 usd
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4204000 usd
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3039000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8824000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7145000 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3196000 usd
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2434000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5617000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4373000 usd
CY2022Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
34000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
376000 usd
CY2021Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
44000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
66000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
88000 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
7434000 usd
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
5517000 usd
us-gaap Operating Expenses
OperatingExpenses
14507000 usd
us-gaap Operating Expenses
OperatingExpenses
11606000 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-7434000 usd
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-5517000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-14507000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-11606000 usd
CY2022Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-603000 usd
CY2021Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-1173000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-763000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-2750000 usd
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
15000 usd
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
8000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
20000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
18000 usd
CY2022Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
39000 usd
CY2021Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
92000 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
80000 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
149000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-6777000 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-4244000 usd
us-gaap Net Income Loss
NetIncomeLoss
-13644000 usd
us-gaap Net Income Loss
NetIncomeLoss
-8689000 usd
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.24
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.15
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.48
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.35
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28583014
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28451532
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28580689
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25148399
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-6777000 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-4244000 usd
us-gaap Net Income Loss
NetIncomeLoss
-13644000 usd
us-gaap Net Income Loss
NetIncomeLoss
-8689000 usd
CY2022Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-31000 usd
CY2021Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-6000 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-19000 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-10000 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-6808000 usd
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4250000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-13663000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-8699000 usd
us-gaap Net Income Loss
NetIncomeLoss
-13644000 usd
us-gaap Net Income Loss
NetIncomeLoss
-8689000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
66000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
88000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1041000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
838000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-763000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
319000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-2750000 usd
mbrx Operating Lease Noncash Expense Net
OperatingLeaseNoncashExpenseNet
84000 usd
mbrx Operating Lease Noncash Expense Net
OperatingLeaseNoncashExpenseNet
109000 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
1729000 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
305000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1820000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-19000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-10000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-12904000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
64333000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
70903000 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
15173000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
57999000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-72000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-12806000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-10405000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
67000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
-0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-67000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
63000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
12000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
-0 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
74685000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-12000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
74748000 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
79506000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
3000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
0 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
78993000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
527000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-6867000 usd
CY2022Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
12000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
72665000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-12000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
514000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-6777000 usd
CY2022Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-31000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
66359000 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
17760000 usd
CY2021Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
74684000 usd
CY2021Q1 mbrx Stockholders Equity Adjustments Reverse Stock Split
StockholdersEquityAdjustmentsReverseStockSplit
0 usd
CY2021Q1 mbrx Stock Issued During Period Value Warrant Exercises
StockIssuedDuringPeriodValueWarrantExercises
116000 usd
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
405000 usd
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-4445000 usd
CY2021Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-4000 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
88516000 usd
CY2021Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1000 usd
CY2021Q2 mbrx Subscription Of Common Stock Value
SubscriptionOfCommonStockValue
0 usd
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
433000 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-4244000 usd
CY2021Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-6000 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
84700000 usd
us-gaap Use Of Estimates
UseOfEstimates
<b>Use of Estimates -</b> The preparation of these condensed consolidated financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates. Management considers many factors in selecting appropriate financial accounting policies and controls, and in developing the estimates and assumptions that are used in the preparation of these financial statements. Management must apply significant judgment in this process. In addition, other factors <em style="font: inherit;"> may </em>affect estimates, including expected business and operational changes, sensitivity and volatility associated with the assumptions used in developing estimates, and whether historical trends are expected to be representative of future trends. The estimation process often <em style="font: inherit;"> may </em>yield a range of potentially reasonable estimates of the ultimate future outcomes and management must select an amount that falls within that range of reasonable estimates. This process <em style="font: inherit;"> may </em>result in actual results differing materially from those estimated amounts used in the preparation of financial statements. Estimates are used in the following areas, among others: fair value estimates on intangible assets, warrants, and stock-based compensation expense, as well as accrued expenses and taxes.
us-gaap Net Income Loss
NetIncomeLoss
-13600000 usd
us-gaap Net Income Loss
NetIncomeLoss
-8700000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-12800000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-10400000 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-86500000 usd
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
58000000.0 usd
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
514000 usd
CY2022Q2 us-gaap Prepaid Insurance
PrepaidInsurance
1262000 usd
CY2021Q4 us-gaap Prepaid Insurance
PrepaidInsurance
589000 usd
CY2022Q2 mbrx Prepaid Sponsored Research Current
PrepaidSponsoredResearchCurrent
1124000 usd
CY2021Q4 mbrx Prepaid Sponsored Research Current
PrepaidSponsoredResearchCurrent
474000 usd
CY2022Q2 mbrx Vendor Prepayments And Deposits
VendorPrepaymentsAndDeposits
904000 usd
CY2021Q4 mbrx Vendor Prepayments And Deposits
VendorPrepaymentsAndDeposits
486000 usd
CY2022Q2 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
28000 usd
CY2021Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
22000 usd
CY2022Q2 us-gaap Nontrade Receivables Current
NontradeReceivablesCurrent
5000 usd
CY2021Q4 us-gaap Nontrade Receivables Current
NontradeReceivablesCurrent
23000 usd
CY2022Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3323000 usd
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1594000 usd
CY2022Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4900000
CY2021Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4000000.0
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4800000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3900000
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
433000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1041000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
838000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
832832
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.26
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.49
us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
28368
CY2022Q2 mbrx Accrued Research And Development Current
AccruedResearchAndDevelopmentCurrent
1508000 usd
CY2021Q4 mbrx Accrued Research And Development Current
AccruedResearchAndDevelopmentCurrent
1005000 usd
CY2022Q2 mbrx Accrued Legal Regulatory Professional And Other Current
AccruedLegalRegulatoryProfessionalAndOtherCurrent
835000 usd
CY2021Q4 mbrx Accrued Legal Regulatory Professional And Other Current
AccruedLegalRegulatoryProfessionalAndOtherCurrent
442000 usd
CY2022Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
139000 usd
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
606000 usd
CY2022Q2 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
95000 usd
CY2021Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
109000 usd
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2675000 usd
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2258000 usd
CY2021Q4 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
48000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0 pure
CY2022Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
29000 usd
CY2021Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
29000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
58000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
58000 usd
CY2022Q2 us-gaap Variable Lease Cost
VariableLeaseCost
7000 usd
CY2021Q2 us-gaap Variable Lease Cost
VariableLeaseCost
7000 usd
us-gaap Variable Lease Cost
VariableLeaseCost
14000 usd
us-gaap Variable Lease Cost
VariableLeaseCost
14000 usd
CY2022Q2 us-gaap Lease Cost
LeaseCost
36000 usd
CY2021Q2 us-gaap Lease Cost
LeaseCost
36000 usd
us-gaap Lease Cost
LeaseCost
72000 usd
us-gaap Lease Cost
LeaseCost
72000 usd
CY2022Q2 mbrx Lessee Operating Lease Monthly Rent Average Increase Rate
LesseeOperatingLeaseMonthlyRentAverageIncreaseRate
0.03 pure
CY2022Q2 us-gaap Sublease Income
SubleaseIncome
10000 usd
us-gaap Sublease Income
SubleaseIncome
21000 usd
CY2022Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
35000 usd
CY2021Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
34000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
70000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
68000 usd
CY2022Q2 mbrx License Agreements Expense
LicenseAgreementsExpense
56000 usd
mbrx License Agreements Expense
LicenseAgreementsExpense
133000 usd
mbrx License Agreements Expense
LicenseAgreementsExpense
94000 usd

Files In Submission

Name View Source Status
0001437749-22-020389-index-headers.html Edgar Link pending
0001437749-22-020389-index.html Edgar Link pending
0001437749-22-020389.txt Edgar Link pending
0001437749-22-020389-xbrl.zip Edgar Link pending
ex_377899.htm Edgar Link pending
ex_377900.htm Edgar Link pending
ex_377901.htm Edgar Link pending
ex_377902.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
mbrx-20220630.xsd Edgar Link pending
mbrx20220630_10q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
moleculinnewlogoresized.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
mbrx-20220630_lab.xml Edgar Link unprocessable
mbrx-20220630_pre.xml Edgar Link unprocessable
mbrx20220630_10q_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable
mbrx-20220630_cal.xml Edgar Link unprocessable
mbrx-20220630_def.xml Edgar Link unprocessable